Th2 Cytokines Increase Staphylococcus Aureus Alpha Toxin-induced Keratinocyte Death Through the Signal Transducer and Activator of Transcription 6 (STAT6)

Overview

Journal J Invest Dermatol

Publisher Elsevier

Specialty Dermatology

Date 2014 Jan 29

PMID 24468745

Citations 48

Authors

Anne M Brauweiler

Elena Goleva

Donald Y M Leung

Affiliations

Soon will be listed here.

Abstract

Atopic dermatitis (AD) is an inflammatory skin disease characterized by increased T-helper type 2 (Th2) cytokine expression. AD skin lesions are often exacerbated by Staphylococcus aureus-mediated secretion of the lytic virulence factor, alpha toxin. In the current study, we report that alpha toxin-induced cell death is greater in the skin from patients with AD compared with controls. Furthermore, we find that keratinocyte differentiation and Th2 cytokine exposure influence sensitivity to S. aureus alpha toxin-induced cell death. Differentiated keratinocytes are protected from cell death, whereas cells treated with Th2 cytokines have increased sensitivity to alpha toxin-induced lethality. Our data demonstrate that the downstream effects mediated by Th2 cytokines are dependent upon host expression of STAT6. We determine that Th2 cytokines induce biochemical changes that decrease levels of acid sphingomyelinase (SMase), an enzyme that cleaves sphingomyelin, an alpha toxin receptor. Furthermore, Th2 cytokines inhibit the production of lamellar bodies, organelles critical for epidermal barrier formation. Finally, we determine that SMase and its enzymatic product, phosphocholine, prevent Th2-mediated increases in alpha toxin-induced cell death. Therefore, our studies may help explain the increased propensity for Th2 cytokines to exacerbate S. aureus-induced skin disease, and provide a potential therapeutic target for treatment of AD.

Citing Articles

Infections in Patients with Atopic Dermatitis and the Influence of Treatment.

Napolitano M, Esposito M, Fargnoli M, Girolomoni G, Romita P, Nicoli E Am J Clin Dermatol. 2025; 26(2):183-197.

PMID: 39915363 PMC: 11850493. DOI: 10.1007/s40257-025-00917-z.

Skin microbiota: pathogenic roles and implications in atopic dermatitis.

Huang C, Zhuo F, Guo Y, Wang S, Zhang K, Li X Front Cell Infect Microbiol. 2025; 14:1518811.

PMID: 39877655 PMC: 11772334. DOI: 10.3389/fcimb.2024.1518811.

Preclinical Models of Atopic Dermatitis Suitable for Mechanistic and Therapeutic Investigations.

Maskey A, Mo X, Li X J Inflamm Res. 2024; 17:6955-6970.

PMID: 39372589 PMC: 11456296. DOI: 10.2147/JIR.S467327.

Transcriptional Profiling of during the Transition from Asymptomatic Nasal Colonization to Skin Colonization/Infection in Patients with Atopic Dermatitis.

Li P, Schulte J, Wurpts G, Hornef M, Wolz C, Yazdi A Int J Mol Sci. 2024; 25(17).

PMID: 39273114 PMC: 11394835. DOI: 10.3390/ijms25179165.

Adding Fuel to the Fire? The Skin Microbiome in Atopic Dermatitis.

Saheb Kashaf S, Kong H J Invest Dermatol. 2024; 144(5):969-977.

PMID: 38530677 PMC: 11034722. DOI: 10.1016/j.jid.2024.01.011.

References

Wertz P, Downing D, FREINKEL R, Traczyk T . Sphingolipids of the stratum corneum and lamellar granules of fetal rat epidermis. J Invest Dermatol. 1984; 83(3):193-5. DOI: 10.1111/1523-1747.ep12263553. View

Pillai S, Bikle D, Hincenbergs M, Elias P . Biochemical and morphological characterization of growth and differentiation of normal human neonatal keratinocytes in a serum-free medium. J Cell Physiol. 1988; 134(2):229-37. DOI: 10.1002/jcp.1041340208. View

Kim B, Bin L, Ye Y, Ramamoorthy P, Leung D . IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication. J Invest Dermatol. 2013; 133(12):2678-2685. PMC: 3785566. DOI: 10.1038/jid.2013.223. View

Valeva A, Hellmann N, Walev I, Strand D, Plate M, Boukhallouk F . Evidence that clustered phosphocholine head groups serve as sites for binding and assembly of an oligomeric protein pore. J Biol Chem. 2006; 281(36):26014-21. DOI: 10.1074/jbc.M601960200. View

Travers J, Norris D, Leung D . The keratinocyte as a target for staphylococcal bacterial toxins. J Investig Dermatol Symp Proc. 2002; 6(3):225-30. DOI: 10.1046/j.0022-202x.2001.00045.x. View

Klevens R, Morrison M, Nadle J, Petit S, Gershman K, Ray S . Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007; 298(15):1763-71. DOI: 10.1001/jama.298.15.1763. View

Wichmann K, Uter W, Weiss J, Breuer K, Heratizadeh A, Mai U . Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol. 2009; 161(2):300-5. DOI: 10.1111/j.1365-2133.2009.09229.x. View

Albanesi C, Fairchild H, Madonna S, Scarponi C, De Pita O, Leung D . IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J Immunol. 2007; 179(2):984-92. DOI: 10.4049/jimmunol.179.2.984. View

Travagli J, Letourneur M, Bertoglio J, Pierre J . STAT6 and Ets-1 form a stable complex that modulates Socs-1 expression by interleukin-4 in keratinocytes. J Biol Chem. 2004; 279(34):35183-92. DOI: 10.1074/jbc.M403223200. View

10.

Howell M, Kim B, Gao P, Grant A, Boguniewicz M, DeBenedetto A . Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007; 120(1):150-5. PMC: 2669594. DOI: 10.1016/j.jaci.2007.04.031. View

11.

Brauweiler A, Bin L, Kim B, Oyoshi M, Geha R, Goleva E . Filaggrin-dependent secretion of sphingomyelinase protects against staphylococcal α-toxin-induced keratinocyte death. J Allergy Clin Immunol. 2012; 131(2):421-7.e1-2. PMC: 3742335. DOI: 10.1016/j.jaci.2012.10.030. View

12.

Nardo A, Wertz P, Giannetti A, Seidenari S . Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol. 1998; 78(1):27-30. DOI: 10.1080/00015559850135788. View

13.

Suarez-Farinas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman Strong C . Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol. 2013; 132(2):361-70. PMC: 3991240. DOI: 10.1016/j.jaci.2013.04.046. View

14.

Grayson S, Wintroub B, Isseroff R, Epstein Jr E, Elias P . Lamellar body-enriched fractions from neonatal mice: preparative techniques and partial characterization. J Invest Dermatol. 1985; 85(4):289-94. DOI: 10.1111/1523-1747.ep12276826. View

15.

Kim B, Leung D, Boguniewicz M, Howell M . Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol. 2008; 126(3):332-7. PMC: 2275206. DOI: 10.1016/j.clim.2007.11.006. View

16.

Pilgram G, Vissers D, van der MEULEN H, Pavel S, Lavrijsen S, Bouwstra J . Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol. 2001; 117(3):710-7. DOI: 10.1046/j.0022-202x.2001.01455.x. View

17.

Elias P, Wakefield J . Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Clin Rev Allergy Immunol. 2010; 41(3):282-95. PMC: 4565600. DOI: 10.1007/s12016-010-8231-1. View

18.

Boguniewicz M, Leung D . Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011; 242(1):233-46. PMC: 3122139. DOI: 10.1111/j.1600-065X.2011.01027.x. View

19.

Uchida Y, Murata S, Schmuth M, Behne M, Lee J, Ichikawa S . Glucosylceramide synthesis and synthase expression protect against ceramide-induced stress. J Lipid Res. 2002; 43(8):1293-302. View

20.

Valeva A, Walev I, Pinkernell M, Walker B, Bayley H, Palmer M . Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci U S A. 1997; 94(21):11607-11. PMC: 23553. DOI: 10.1073/pnas.94.21.11607. View